Medication-Related Osteonecrosis of the Jaws: Dental Aspects of Pathophysiology, Risk Factors and Preventive Measures
Akdeniz Diş Hekimliği Dergisi · 29.04.2026 · 5 (1) · 77-88
DOI: 10.62268/add.1810597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Akdeniz Diş Hekimliği Dergisi, online erschienen am 29.04.2026. Verfasst von Elif Aslan. Die Arbeit nennt 77 Literaturangaben. Gefördert von: The authors declared that this study has received no financial support..
Abstract (Originalsprache)
Medication-related osteonecrosis of the jaw (MRONJ) is defined as a progressive destruction of the jawbones, which occurs as a result of the adverse effects of antiresorptive drugs. Although multiple pathophysiological processes and numerous risk factors have been reported to contribute to the development of MRONJ, pathophysiological mechanisms of different factors cause varying rates of MRONJ development in different patients. Understanding the relationship between pathophysiological processes and risk factors is crucial for healthcare providers to take necessary precautions before initiating antiresorptive drug therapy. Accordingly, the identification and elimination of focal infections and/or trauma sites by a comprehensive clinical and radiographic examination prior to antiresorptive drug therapy has been accepted as the primary strategy for preventing MRONJ. Therefore, it is particularly imperative for dental professionals to possess adequate and recent knowledge regarding the pathophysiology and risk factors of MRONJ for the adequate identification of the existing risk factors in patients undergoing antiresorptive therapy and the effective prevention of the development of MRONJ. The aim of this review was to evaluate the pathophysiological processes and risk factors involved in the development of MRONJ and to discuss preventive measures from a dental perspective and in the guidance of the current literature.
Förderung
- The authors declared that this study has received no financial support.
Zitieren
APA
Aslan, E. (2026). Medication-Related Osteonecrosis of the Jaws: Dental Aspects of Pathophysiology, Risk Factors and Preventive Measures. Akdeniz Diş Hekimliği Dergisi, 5(1), 77-88. https://doi.org/10.62268/add.1810597
Vancouver
Aslan E. Medication-Related Osteonecrosis of the Jaws: Dental Aspects of Pathophysiology, Risk Factors and Preventive Measures. Akdeniz Diş Hekimliği Dergisi. 2026;5(1):77-88. doi:10.62268/add.1810597
BibTeX
@article{Aslan2026,
author = {Aslan, Elif},
title = {Medication-Related Osteonecrosis of the Jaws: Dental Aspects of Pathophysiology, Risk Factors and Preventive Measures},
journal = {Akdeniz Diş Hekimliği Dergisi},
year = {2026},
volume = {5},
number = {1},
pages = {77--88},
doi = {10.62268/add.1810597}
}
EUVIMED